Abliva decides on a SEK 200 million financing to fund Phase 2/3 study of KL1333…
Continue Reading-
Gesynta Pharma’s drug candidate GS-248 granted Orphan Drug Designation by the FDA
Gesynta Pharma’s drug candidate GS-248 granted Orphan Drug Designation by the FDA — Hadean Ventures…
Continue Reading -
Alex Therapeutics raises €3.5M in oversubscribed financing round
Alex Therapeutics aspires to become the global go-to partner for pharma, and other life-science companies…
Continue Reading -
TargED Biopharmaceuticals raises EUR 39 Million in Series A financing
TargED Biopharmaceuticals raises EUR 39 Million in Series A financing
Continue Reading -
Ribbon Biolabs raises EUR 18 million in its Series A financing
Ribbon Biolabs Raises EUR 18 Million Series A Financing
Continue Reading -
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC — Hadean Ventures…
Continue Reading -
Hadean Ventures Announces the 1st Closing of EUR 90m for its Second Fund
Hadean Ventures Announces the 1st Closing of EUR 90m for its Second Fund...
Continue Reading -
Cardior raises €64 M Series B to advance clinical pipeline of RNA therapeutics to treat Cardiac Disease
Cardior raises €64 M Series B to advance clinical pipeline of RNA therapeutics to treat…
Continue Reading -
Attgeno appoints Björn Westberg as CFO
Attgeno appoints Björn Westberg as CFO — Hadean Ventures Home Portfolio Team Impact Investors News…
Continue Reading -
SAGA Diagnostics raises €10.5 million
SAGA Diagnostics raises SEK 106 million (€10.5 million)...
Continue Reading